Journal Mobile Options
Table of Contents
Vol. 53, Suppl. 1, 2000
Issue release date: July 2000
Horm Res 2000;53(suppl 1):12–18

Molecular Pathogenesis of Neonatal Hypothyroidism

Krude H. · Biebermann H. · Schnabel D. · Ambrugger P. · Grüters A.
Department of Pediatrics, Charité University Hospital, Humboldt University, Berlin, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


In patients with congenital hypothyroidism (CH), the autosomal recessive inheritance of mutations of thyroid peroxidase, thyroglobulin and the NIS and pendrin genes encoding for sodium iodide transporters has been identified. CH due to thyroid dysgenesis was considered to be a sporadic disease, but recently, inheritable defects of thyroid development have been described. The autosomal recessive inheritance of mutations of the thyroid-stimulating hormone receptor gene was recognized in patients with CH and thyroid hypoplasia, while autosomal dominant mutations of the Pax-8 gene were described in patients with thyroid dysgenesis. In addition, analysis of mutations of the β-thyrotropin gene has resulted in a new understanding of the pathogenesis of central CH. Molecular genetic studies in patients with CH detected by newborn screening will provide the information necessary for genetic counselling and may help to explain the less favourable outcome present in 5–10% of the patients.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bikker H, den Hartog MT, Baas F, Gons MH, Vulsma T, de Vijlder JJ: A 20-basepair duplication in the human thyroid peroxidase gene results in a total iodide organification defect and congenital hypothyroidism. J Clin Endocrinol Metab 1994;79:248–252.
  2. Bikker H, Vulsma T, Baas F, de Vijlder JJ: Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis. Hum Mutat 1995;6:9–16.
  3. Bikker H, Waelkens JJ, Bravenboer B, de Vijlder JJ: Congenital hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene. J Clin Endocrinol Metab 1996;81:2076–2079.
  4. Grüters A, Köhler B, Wolf A, Söling A, de Vijlder L, Krude H, Biebermann H: Screening for mutations of the human thyroid peroxidase gene in patients with congenital hypothyroidism. Exp Clin Endocrinol Diabetes 1996;104(suppl 4):121–123.
  5. Ieri T, Cochaux P, Tagorvnik HM, Suzuki M, Shimoda SI, Pereet J, Vassart G: A 3′ splice mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 1991;88:1901–1905.

    External Resources

  6. Coyle B, Reardon W, Herbrick JA, Tsui LC, Gausden E, Lee J, Coffey R, Grüters A, Grossman A, Phelps PD, Luxon L, Kendall-Taylor P, Scherer SW, Trembath RC: Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet 1998;7:1105–1112.

    External Resources

  7. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S: Congenital hypothyroidism due to mutations in the sodium/iodide symporter: Identification of a nonsense mutation producing a downstream cryptic 3′ splice site. J Clin Invest 1998;101:1028–1035.
  8. Biebermann H, Schoneberg T, Krude H, Schultz G, Gudermann T, Grüters A: Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 1997;82:3471–3480.
  9. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C: Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997;99:3018–3024.
  10. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Grüters A, Busslinger M, Di Lauro R: PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 1998;19:83–86.
  11. Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, Takai S, Amino N: Congenital hypothyroidism caused by a mutation in the Na+/I symporter. Nat Genet 1997;16:124–125.

    External Resources

  12. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411–422.
  13. Scott DA, Wang R, Kreman TM, Sheffield VC, Karnishki LP: The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 1999;21:440–443.
  14. Stanbury JB, Rocmans P, Buhler UK, Ochi Y: Congenital hypothyroidism with impaired thyroid response to thyrotropin. N Engl J Med 1968;279:1132–1136.

    External Resources

  15. Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R, Boguszewski MC, Hollenberg AN, Radovick S, Wondisford FE: A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 1996;97:1250–1256.
  16. Gagné N, Parma J, Deal C, Vassart G, van Vliet G: Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: Are athyreosis and ectopic thyroid distinct entities. J Clin Endocrinol Metab 1998;83:1771–7175.
  17. Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S: Brief report: Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995;332:155–160.
  18. Clifton-Bligh RJ, Gregory JW, Ludgate M, John R, Persani L, Asteria C, Beck-Peccoz P, Chatterjee VK: Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab 1997;82:1094–1100.
  19. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ: The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60–69.
  20. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K, Macchia PE, Mattei MG, Mariano A, Scholer H, Macchia V, Di Lauro R: A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 1998;19:395–398.
  21. Lapi P, Macchia PE, Chiovato L, Biffali E, Moschini L, Larizza D, Baserga M, Pinchera A, Fenzi G, Di Lauro R: Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid 1997;7:383–387.
  22. Devriendt K, Vanhole C, Matthijs G, de Zegher F: Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317–1318.
  23. Bamforth JS, Hughes IA, Lazarus JH, Weaver CM, Harper PS: Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 1989;26:49–51.
  24. Buntincx IM, Van Overmeire B, Desager K, Van Hauwaert J: Syndromic association of cleft palate, bilateral choanal atresia, curly hair, and congenital hypothyroidism. J Med Genet 1993;30:427–428.

    External Resources

  25. Lapi P, Macchia PE, Krude H, Chiovato L, Grüters A, Fenzi GF, Di Lauro R: Research for mutations in the TTF-2 gene in cases of congenital hypothyroidism due to thyroid dysgenesis. J Endocrinol Invest 1998;21:37.
  26. Pfäffle RW, Parks JS, Brown MR, Ingraham HA, Di Mattia G, Wit JM: A mutation of pit-1 in two families with multiple pituitary hormone deficiencies. Eur J Pediatr 1992;151:229–240.
  27. Collu R, Tang J, Castagne J, Lagace G, Masson N, Huot C, Deal C, Delvin E, Faccenda E, Eidne KA, Van Vliet G: A novel mechanism for isolated central hypothyroidism: Inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997;82:561–565.
  28. Dacou-Voutetakis C, Feltquate DM, Drakopoulou M, Kourides IA, Dracopoli NC: Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulating hormone beta-subunit gene. Am J Hum Genet 1990;6:988–993.
  29. Doeker BM, Pfäffle RW, Pohlenz J, Andler W: Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance. J Clin Endocrinol Metab 1998;83:1762–1765.
  30. Grüters A, Liesenkötter KP, Zapico M, Jenner A, Dutting C, Pfeiffer E, Lehmkuhl U: Results of the screening program for congenital hypothyroidism in Berlin (1978–1995). Exp Clin Endocrinol Diabetes 1997;105(suppl 4):28–31.
  31. Grüters A: Screening for congenital hypothyroidism: Effectiveness and clinical outcome. Baillières Clin Pediatr 1996;4:259–277.
  32. Lazzaro D, Price M, de Felice M, Di Lauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093–1104.
  33. Biebermann H, Liesenkötter KP, Emeis M, Oblanden M, Grüters A: Severe congenital hypothyroidism due to a homozygous mutation of the betaTSH gene. Pediatr Res 1999;46:170–173.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50